RSERX Performance — Victory Sophus Emerging Markets Fund, Class R6
Data updated: 2025-05-29
RSERX returned +6.09% over one year to Mar 2025. Annualised returns are +1.07% over 3 years and +8.01% over 5 years. Against its Emerging Markets Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $103, against $105 for the category, and to $106 over one year, against $106. Volatility over the past three years was 16.97% a year. In the 12 months to Mar 2025 the fund lost a net $117.5M, and assets reached $308.56M.
RSERX Growth of $100
What $100 invested in Victory Sophus Emerging Markets Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | RSERX | Category average |
|---|---|---|
| 1 year (Apr 2024 – Mar 2025) | $106 | $106 |
| 3 years (Apr 2022 – Mar 2025) | $103 | $105 |
| 5 years (Apr 2020 – Mar 2025) | $147 | $149 |
| Since data start (Jul 2019 – Mar 2025) | $121 | $124 |
RSERX Trailing Returns
Total returns to Mar 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +6.09% |
| 3 years (annualised) | +1.07% |
| 5 years (annualised) | +8.01% |
RSERX Annual Returns
Calendar-year total returns of Victory Sophus Emerging Markets Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Mar) | +5.08% |
| 2024 | +5.67% |
| 2023 | +11.43% |
| 2022 | −22.06% |
| 2021 | −3.92% |
| 2020 | +17.29% |
| 2019 (Jul–Dec) | +10.94% |
RSERX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +3.1% | 0.0% | +1.9% | — | — | — | — | — | — | — | — | — |
| 2024 | −2.7% | +5.0% | +2.5% | +0.4% | +0.9% | +4.0% | −1.4% | 0.0% | +3.5% | −4.6% | −2.2% | +0.7% |
| 2023 | +9.4% | −6.7% | +3.3% | −1.0% | −1.1% | +5.2% | +5.2% | −5.2% | −2.3% | −4.6% | +7.9% | +2.5% |
| 2022 | +0.8% | −4.3% | −3.1% | −5.9% | +1.6% | −8.9% | +0.2% | −1.0% | −10.8% | −0.8% | +12.9% | −3.2% |
| 2021 | +3.7% | +2.5% | −0.9% | +2.3% | +1.4% | +1.4% | −6.6% | +1.2% | −4.9% | +0.3% | −5.9% | +2.3% |
| 2020 | −5.6% | −2.7% | −19.5% | +9.2% | +2.9% | +7.2% | +8.6% | +2.2% | −0.8% | +1.7% | +8.6% | +8.4% |
| 2019 | — | — | — | — | — | — | −1.1% | −3.2% | +1.9% | +4.6% | +0.1% | +8.7% |
RSERX Risk
Risk measures from monthly returns over Apr 2022 – Mar 2025.
- 3-year volatility (annualised): 16.97%
- 3-year Sharpe ratio: -0.20 (vs 4.5% risk-free rate)
- Best month: +12.87% (Nov 2022)
- Worst month: −10.75% (Sep 2022)
RSERX Fund Flows
Monthly money in and out of Victory Sophus Emerging Markets Fund, from SEC Form N-PORT.
- 12-month net flow: −$117.5M
- 12-month gross sales (incl. reinvestments): $64.2M
- Sales ÷ redemptions: 0.35×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Mar 2025 | $3.1M | $4.7M | −$1.7M |
| Feb 2025 | $3.8M | $45.4M | −$41.5M |
| Jan 2025 | $5.6M | $15.1M | −$9.5M |
| Dec 2024 | $13.8M | $11.4M | $2.4M |
| Nov 2024 | $6.0M | $7.4M | −$1.4M |
| Oct 2024 | $5.1M | $4.0M | $1.2M |
| Sep 2024 | $4.0M | $4.7M | −$726K |
| Aug 2024 | $5.3M | $4.3M | $1.0M |
| Jul 2024 | $4.0M | $9.2M | −$5.1M |
| Jun 2024 | $3.0M | $6.4M | −$3.3M |
| May 2024 | $4.6M | $39.4M | −$34.8M |
| Apr 2024 | $5.8M | $29.8M | −$24.0M |
RSERX Assets Under Management
Net assets of Victory Sophus Emerging Markets Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-03-31 | $308.56M |
| 2024-12-31 | $343.66M |
| 2024-09-30 | $372.16M |
| 2024-06-30 | $369.76M |
| 2024-03-31 | $411.02M |
| 2023-12-31 | $380.83M |
| 2023-09-30 | $375.79M |
| 2023-06-30 | $397.89M |
| 2023-03-31 | $416.26M |
| 2022-12-31 | $401.03M |
| 2022-09-30 | $382.66M |
| 2022-06-30 | $431.70M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.